| Univariable Analysis | |
---|---|---|
 | Hazard ratio (CI) | p-value |
Clinical variables | Â | Â |
Age | 1.03 (1.01-1.05 | 0.001 |
Female Gender | 2.00 (1.31-3.07) | 0.002 |
Diabetes Mellitus | 1.26 (0.82-1.940 | 0.3 |
Hypertension | 0.95 (0.62-1.46) | 0.8 |
Statins | 0.74 (0.49-1.12) | 0.1 |
Beta-blockers | 0.71 (0.47-1.06) | 0.1 |
Angiotensin converting enzyme-inhibitors | 0.75 (0.49-1.14) | 0.2 |
Aldosterone antagonists | 1.17 (0.74-1.86) | 0.5 |
Post-CMR coronary bypass grafting | 0.62 (0.41-0.93) | 0.02 |
Post-CMR mitral valve repair/replacement | 1.10 (0.68-1.79) | 0.7 |
Post-CMR defibrillator/resynchronization therapy | 0.73 (0.45-1.20) | 0.2 |
Echocardiographic variables | Â | Â |
Vena contracta | 5.70 (2.94-11.04) | < 0.001 |
CMR variables | Â | Â |
LV ejection fraction | 0.98 (0.96-1.003) | 0.1 |
LV end-diastolic volume index | 1.004 (0.99-1.008) | 0.1 |
Indexed left atrial volume | 1.006 (0.99-1.02) | 0.3 |
Indexed (D1+D2+D3)/3L (cm/m2) | 1.23 (1.06-1.44) | 0.007 |
Semiquantitative total scar score | 1.21 (1.00-1.46) | 0.04 |
Semiquantitative regional scar score | Â | Â |
Anterior | 1.06 (0.90-1.23) | 0.5a |
Lateral | 1.13 (0.97-1.31) | 0.1 |
Inferior | 1.24 (1.06-1.44) | 0.008 |